Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure

European Journal of Medical Research

Volumn 14, Issue 3, 2009, Pages 113-117

  Fritzenwanger, Michael ^a   Lorenz, F ^a   Jung, C ^a   Fabris, M ^a   Thude, H ^a   Barz, D ^a   Figulla, H R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

CD133; CD34; Congestive heart failure; Progenitor cell

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CELL MARKER; VASCULOTROPIN C;

AGED; ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL FUNCTION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PERIPHERAL BLOOD STEM CELL; PERIPHERAL VEIN; VENOUS BLOOD;

EID: 63349095720     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-14-3-113     Document Type: Article

References (20)

1. McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005 May 28-Jun 3;365(9474):1877-89.
2. Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med. 2005;56:79-101.
3. Agnoletti L, Curello S, Bachetti T, Malacarne F, Gaia G, Comini L, Volterrani M, Bonetti P, Parrinello G, Cadei M, Grigolato PG, Ferrari R. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation. 1999 Nov 9;100(19):1983-91.
4. Andreou I, Tousoulis D, Tentolouris C, Antoniades C, Stefanadis C. Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives. Atherosclerosis. 2006 Dec;189(2): 247-54. Epub 2006 Jul 24.
5. Luttun A, Carmeliet G, Carmeliet P. Vascular progenitors: from biology to treatment. Trends Cardiovasc Med. 2002 Feb;12(2):88-96.
6. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. Endotheial progenitor cells: new hope for a broken heart. Circulation. 2003 Jun 24;107(24):3093-100.
7. Prater DN, Case J, Ingram DA, Yoder MC. Working hypothesis to redefine endothelial progenitor cells. Leukemia 2007;21:1141-1149.
8. Shaffer RG, Greene S, Arshi A, Supple G, Bandy A, Moore JS, Mohler ER 3rd. Flow cytometric measurement of circulating endotheial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry B Clin Cytom. 2006 70:56-62.
9. Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J, Simm A. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2003; 42(12):2073-80.
10. Nonaka-Sarukawa M, Yamamoto K, Aoki H, Nishimura Y, Tomizawa H, Ichida M, Eizawa T, Muroi K, Ikeda U, Shimada K. Circulating endotheial progenitor cells in congestive heart failure. Int J Cardiol. 2007;119(3):344-8. Epub 2006 Oct 27.
11. Theiss HD, David R, Engelmann MG, Barth A, Schotten K, Naebauer M, Reichart B, Steinbeck G, Franz WM. Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur Heart J. 2007;28(10):1258-64. Epub 2007 Mar 29.
12. Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation. 2004;110(10): 1209-12. Epub 2004 Jul 12.
13. Michowitz Y, Goldstein E, Wexler D, Sheps D, Keren G, George J. Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure. Heart. 2007;93(9):1046-50. Epub 2007 Feb 3.
14. Schatteman G. Are circulating CD133+ cells biomarkers of vascular disease? Arterioscler Thromb Vasc Biol. 2005; 25(2):270-1.
15. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endotheial precursors. Blood. 2000 Feb 1;95(3): 952-8.
16. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol. 2001 Oct;115(1):186-94.
17. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004;109(13):1615-22. Epub 2004 Mar 22.
18. Iversen PO, Woldbaek PR, Tøonnessen T, Christensen G. Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol Regul Integr Comp Physiol. 2002;282(1):R166-72.
19. Geft D, Schwartzenberg S, Rogowsky O, Finkelstein A, Ablin J, Maysel-Auslender S, Wexler D, Keren G, George J. Circulating apoptotic progenitor cells in patients with congestive heart failure. PLoS ONE. 2008 Sep 18;3(9): e3238.
20. Kissel CK, Lehmann R, Assmus B, Aicher A, Honold J, Fischer-Rasokat U, Heeschen C, Spyridopoulos I, Dimmeler S, Zeiher AM. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol. 2007;49(24):2341-9.